Dopamine receptor D2 genotype (3438) is associated with moderate/severe endometriosis in infertile women in Brazil

Fertility and Sterility

Volumn 99, Issue 5, 2013, Pages 1340-1345

  Bilibio, João Paolo ^a   Matte, Ursula ^a   De Conto, Emily ^a,b   Genro, Vanessa Krebs ^a   Souza, Carlos Augusto ^a   Cunha Filho, João Sabino ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

dopamine receptor D2; Endometriosis; infertility; polymorphism; prolactin

Indexed keywords

CYTOSINE; DOPAMINE 2 RECEPTOR; HISTIDINE; THYMINE;

ADULT; ARTICLE; BRAZIL; CASE CONTROL STUDY; DISEASE SEVERITY; DNA EXTRACTION; DNA POLYMORPHISM; ENDOMETRIOSIS; EXON; FEMALE; FEMALE INFERTILITY; GENE; GENE FREQUENCY; GENOTYPE; HUMAN; HYPERPROLACTINEMIA; MAJOR CLINICAL STUDY; PERITONEAL ENDOMETRIOSIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; UNIVERSITY HOSPITAL; UTERINE TUBE LIGATION;

ADOLESCENT; ADULT; BRAZIL; CASE-CONTROL STUDIES; ENDOMETRIOSIS; EXONS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INFERTILITY, FEMALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROLACTIN; RECEPTORS, DOPAMINE D2; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; STERILIZATION, TUBAL; YOUNG ADULT;

EID: 84875723673     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2012.11.036     Document Type: Article

References (42)

1. J.S. Cunha-Filho, J.L. Gross, N.A. Lemos, A. Brandelli, M. Castillos, and E.P. Passos Hyperprolactinemia and luteal insufficiency in infertile patients with mild and minimal endometriosis Horm Metab Res 33 2001 216 220
2. G. Gregoriou, P. Bakas, N. Vitoratos, K. Papadias, K. Goumas, and A. Chryssicopoulos Evaluation of serum prolactin levels in patients with endometriosis and infertility Gynecol Obstet Invest 48 1999 48 51
3. A.P. Lima, M.D. Moura, and A.A. Rosa e Silva Prolactin and cortisol levels in women with endometriosis Braz J Med Biol Res 39 2006 1121 1127
4. K. Muse, E.A. Wilson, and M.J. Jawad Prolactin hyperstimulation in response to thyrotropin-releasing hormone in patients with endometriosis Fertil Steril 38 1982 419 422
5. H. Wang, N. Gorpudolo, and B. Behr The role of prolactin- and endometriosis-associated infertility Obstet Gynecol Surv 64 2009 542 547
6. J. Reese, N. Binart, N. Brown, W.G. Ma, B.C. Paria, and S.K. Das Implantation and decidualization defects in prolactin receptor (PRLR)-deficient mice are mediated by ovarian but not uterine PRLR Endocrinology 141 2000 1872 1881
7. E. Novella-Maestre, C. Carda, I. Noguera, A. Ruiz-Sauri, J.A. Garcia-Velasco, and C. Simon Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis Hum Reprod 24 2009 1025 1035
8. C. Missale, S.R. Nash, S.W. Robinson, M. Jaber, and M.G. Caron Dopamine receptors: from structure to function Physiol Rev 78 1998 189 225
9. P. Seeman, and H.H. Van Tol Dopamine receptor pharmacology Trends Pharmacol Sci 15 1994 264 270
10. C. Nilsson, and E. Eriksson Partial dopamine D2 receptor agonists antagonize prolactin-regulating D2 receptors in a transfected clonal cell line (GH4ZR7) Eur J Pharmacol 218 1992 205 211
11. L. Caccavelli, D. Cussac, I. Pellegrini, V. Audinot, P. Jaquet, and A. Enjalbert D2 dopaminergic receptors: normal and abnormal transduction mechanisms Horm Res 38 1992 78 83
12. C.A. Calarge, V.L. Ellingrod, L. Acion, D.D. Miller, J. Moline, and M.J. Tansey Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents Pharmacogenet Genomics 19 2009 373 382
13. K. Mihara, A. Suzuki, T. Kondo, N. Yasui-Furukori, S. Ono, and K. Otani Relationship between Taq1 A dopamine D2 receptor (DRD2) polymorphism and prolactin response to bromperidol Am J Med Genet 105 2001 271 274
14. D.K. Grandy, M. Litt, L. Allen, J.R. Bunzow, M. Marchionni, and H. Makam The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP Am J Hum Genet 45 1989 778 785
15. B. Giros, P. Sokoloff, M.P. Martres, J.F. Riou, L.J. Emorine, and J.C. Schwartz Alternative splicing directs the expression of two D2 dopamine receptor isoforms Nature 342 1989 923 926
16. K.A. Hansen, Y. Zhang, R. Colver, S.P. Tho, L. Plouffe Jr., and P.G. McDonough The dopamine receptor D2 genotype is associated with hyperprolactinemia Fertil Steril 84 2005 711 718
17. American Society for Reproductive Medicine Revised American Society for Reproductive Medicine classification of endometriosis: 1996 Fertil Steril 67 1997 817 821
18. J.H. Abramson WINPEPI (PEPI-for-Windows): computer programs for epidemiologists Epidemiol Perspect Innov 1 2004 6
19. H. Sahai, and A. Khurshid Formulae and tables for the determination of sample sizes and power in clinical trials for testing differences in proportions for the two-sample design: a review Stat Med 15 1996 1 21
20. D.R. Bristol Sample sizes for constructing confidence intervals and testing hypotheses Stat Med 8 1989 803 811
21. A.M. Near, A.H. Wu, C. Templeman, D.J. van den Berg, J.A. Doherty, and M.A. Rossing Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort Fertil Steril 95 2010 40 45
22. R. Cosin, J. Gilabert-Estelles, L.A. Ramon, F. Espana, J. Gilabert, and A. Romeu Vascular endothelial growth factor polymorphisms (-460C/T, +405G/C, and 936C/T) and endometriosis: their influence on vascular endothelial growth factor expression Fertil Steril 92 2009 1214 1220
23. Q.Y. Zhang, Q. Guan, Y. Wang, X. Feng, W. Sun, and F.Y. Kong BDNF Val66Met polymorphism is associated with stage III-IV endometriosis and poor in vitro fertilization outcome Hum Reprod 27 2012 1668 1675
24. M. Itokawa, T. Arinami, and M. Toru Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: Ser311Cys polymorphisms of the dopamine D2-receptor gene and schizophrenia J Pharmacol Sci 114 2010 1 5
25. J. Houston, S. Dharia, J.R. Bishop, V.L. Ellingrod, B. Fijal, and J.G. Jacobson Association of DRD2 and ANKK1 polymorphisms with prolactin increase in olanzapine-treated women Psychiatry Res 187 2011 74 79
26. Y. Wang, X. Liu, Y. Yu, Y. Han, J. Wei, and D. Collier The role of single nucleotide polymorphism of D(2) dopamine receptor gene on major depressive disorder and response to antidepressant treatment Psychiatry Res 200 2012 1047 1050
27. A.H. Wong, C.E. Buckle, and H.H. Van Tol Polymorphisms in dopamine receptors: what do they tell us? Eur J Pharmacol 410 2000 183 203
28. M. Kreitman Nucleotide polymorphism at the alcohol dehydrogenase locus of Drosophila melanogaster Nature 304 1983 412 417
29. L. Malaguarnera, R.M. Imbesi, A. Scuto, F. d'Amico, F. Licata, and A. Messina Prolactin increases HO-1 expression and induces VEGF production in human macrophages J Cell Biochem 93 2004 197 206
30. H.N. Jabbour, H.O. Critchley, and S.C. Boddy Expression of functional prolactin receptors in nonpregnant human endometrium: janus kinase-2, signal transducer and activator of transcription-1 (STAT1), and STAT5 proteins are phosphorylated after stimulation with prolactin J Clin Endocrinol Metab 83 1998 2545 2553
31. F. Delgado-Rosas, R. Gomez, H. Ferrero, F. Gaytan, J. Garcia-Velasco, and C. Simon The effects of ergot and nonergot-derived dopamine agonists in an experimental mouse model of endometriosis Reproduction 142 2011 745 755
32. R. Gomez, A. Abad, F. Delgado, S. Tamarit, C. Simon, and A. Pellicer Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia Fertil Steril 95 2011 882 888 e1
33. E. Novella-Maestre, C. Carda, A. Ruiz-Sauri, J.A. Garcia-Velasco, C. Simon, and A. Pellicer Identification and quantification of dopamine receptor 2 in human eutopic and ectopic endometrium: a novel molecular target for endometriosis therapy Biol Reprod 83 2010 866 873
34. S. Basu, J.A. Nagy, S. Pal, E. Vasile, I.A. Eckelhoefer, and V.S. Bliss The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor Nat Med 7 2001 569 574
35. M.W. Laschke, and M.D. Menger Anti-angiogenic treatment strategies for the therapy of endometriosis Hum Reprod Update 18 2012 682 702
36. S.R. Soares, A. Martinez-Varea, J.J. Hidalgo-Mora, and A. Pellicer Pharmacologic therapies in endometriosis: a systematic review Fertil Steril 98 2012 529 555
37. J.S. Cunha-Filho, J.L. Gross, N.A. Lemos, E.C. Dias, D. Vettori, and C.A. Souza Prolactin and growth hormone secretion after thyrotrophin-releasing hormone infusion and dopaminergic (DA2) blockade in infertile patients with minimal/mild endometriosis Hum Reprod 17 2002 960 965
38. L. Aghajanova, and L.C. Giudice Molecular evidence for differences in endometrium in severe versus mild endometriosis Reprod Sci 18 2011 229 251
39. P.R. Koninckx, A. Ussia, L. Adamyan, A. Wattiez, and J. Donnez Deep endometriosis: definition, diagnosis, and treatment Fertil Steril 98 2012 564 571
40. L. Fedele, S. Bianchi, G. Zanconato, R. Raffaelli, and N. Berlanda Is rectovaginal endometriosis a progressive disease? Am J Obstet Gynecol 191 2004 1539 1542
41. M. Bazot, C. Lafont, R. Rouzier, G. Roseau, I. Thomassin-Naggara, and E. Darai Diagnostic accuracy of physical examination, transvaginal sonography, rectal endoscopic sonography, and magnetic resonance imaging to diagnose deep infiltrating endometriosis Fertil Steril 92 2009 1825 1833
42. M.O. Goncalves, S. Podgaec, J.A. Dias Jr., M. Gonzalez, and M.S. Abrao Transvaginal ultrasonography with bowel preparation is able to predict the number of lesions and rectosigmoid layers affected in cases of deep endometriosis, defining surgical strategy Hum Reprod 25 2010 665 671